4-(Benzo[d][1,3]dioxol-5-yl)thiazol-2-amine

Catalog No. :
ACFDZE063
CAS No. :
185613-91-6
Molecular Formula :
C10H8N2O2S
Molecular Weight :
220.25

IUPAC Name:4-(benzo[d][1,3]dioxol-5-yl)thiazol-2-amine

4-(Benzo[d][1,3]dioxol-5-yl)thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$358.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Benzo[d][1,3]dioxol-5-yl)thiazol-2-amine
IUPAC Name4-(benzo[d][1,3]dioxol-5-yl)thiazol-2-amine
MDL No.MFCD01366560
Molecular FormulaC10H8N2O2S
Molecular Weight220.25
SMILESNC1=NC(C2=CC=C(OCO3)C3=C2)=CS1
InChI KeyAKVSKDDSOWLASE-UHFFFAOYSA-N
Synonym4-BENZO[1,3]DIOXOL-5-YL-THIAZOL-2-YLAMINE;5-(2-AMINO-4-THIAZOLYL)-1,3-BENZODIOXOLE;4-(1,3-BENZODIOXOL-5-YL)-1,3-THIAZOL-2-AMINE;4-(1,3-BENZODIOXOL-5-YL)-1,3-THIAZOL-2-YLAMINE;4-(2H-1,3-Benzodioxol-5-yl)-1,3-thiazol-2-amine;4-(benzo[d][1,3]dioxol-5-yl)thiazol-2-amine;2-Thiazolamine, 4-(1,3-benzodioxol-5-yl)-;Octanoicacid,10-mercapto-
CAS No.185613-91-6
PubChem CID727580

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFDZE063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDZE063 route product structure diagram
    ACFDZE063185613-91-6 In Stock
Inquiry

2. ACFDZE063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSWRK319 route compound structure diagram
    ACSWRK319502145-18-8 In Stock
  2. Plus
  3. ACRHBJ690 route compound structure diagram
    ACRHBJ69094839-07-3 In Stock
  4. Then
  5. ACFDZE063 route product structure diagram
    ACFDZE063185613-91-6 In Stock
Inquiry

Comments (0)